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Abstract
Objectives: Accurate pre-operative imaging of parathyroid adenomas (PAs) is essential for successful minimally invasive
surgery; however, rates of non-localizing PAs can be as high as 18%. Multiphasic dual-energy CT (DECT) has the potential to
increase accuracy of PA detection by enabling creation of pairedmaterial maps and spectral tissue characterization. This study
prospectively evaluated the utility of 3-phase DECT for PA identification in patients with failed localizatio
n via standard imaging.
Methods: Patients with primary hyperparathyroidism and non-localizing PAs underwent a 3 phase post-contrast DECT scan
acquired at 25, 55, and 85 s. The scans were prospectively evaluated by two head and neck radiologists. Pre-operative
localizationwas compared to intraoperative localization and final histopathology. A post-hoc DECT spectral density
characterizationwas performed on pathologically-proven PAs.
Results:Out of 29 patients with primary hyperparathyroidism and non-localized PAs, DECT identified candidates in 26.
Of the 23 patients who underwent parathyroidectomy, DECT provided precise anatomic localization in 20 patients
(PPV = 87.0 %), one with multi-gland disease. The virtual unenhanced images were not found to be useful for diagnosis
but successful diagnosis was made without an unenhanced phase regardless. Spectral analysis demonstrated a distinct
spectral Hounsfield attenuation curve for PAs compared to lymph nodes on arterial phase images.
Conclusion: 3-phase DECT without an unenhanced phase is a feasible salvage imaging modality for previously non-
localizing parathyroid adenomas. Optimal interpretation is achieved based on a combination of perfusion
characteristics and other morphologic features. Advanced spectral DECT analysis has the potential for further increasing
accuracy of PA identification in the future.
Keywords: Parathyroid adenoma, Head and neck surgery, Computed tomography, Dual-energy CT, 4D-CT, 4DCT,
Minimally invasive parathyroidectomy
Background
Accurate pre-operative localization of parathyroid adenomas
(PAs) is essential for successful minimally invasive surgery. At
many institutions, including ours, this is done based on two
concordant studies. Typically, the most common approach
for PA localization is by a combination of sestamibi and ultra-
sound [1, 2]. However, despite their popularity, these tech-
niques have certain pitfalls. Limitations of sestamibi studies
for parathyroid adenoma identification include absent radio-
tracer retention in some adenomas, diminishing sensitivity
with decreasing adenomatous tissue, and potential confound-
ing by concurrent thyroid disease or the occasional hot
thyroid nodule [2]. Sestamibi also has low sensitivity for
multiglandular disease. Ultrasound is operator dependent
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and, in addition, locations where ectopic PAs typically are
located such as deep within the neck, the retropharyngeal
space, and the mediastinum, tend to be areas that are
blind-spots for ultrasound [2]. Reported sensitivities for
the ability to lateralize (localize) PAs to the correct side of
the neck are approximately 57 to 88 % for ultrasound and
65 to 86 % for sestamibi [3]. The addition of SPECT or
SPECT/CT may further increase sensitivity for PAs to ap-
proximately 90 % or more according to some studies [2,
4], but that has not been the experience in our institution.
4-dimensional CT (4D-CT) is increasingly used for
localization of PAs [3, 5–10]. 4D-CT enables characterization
of perfusion characteristics of candidate PAs. The main
principle behind 4D-CT is that PAs have different perfusion
characteristics compared to lymph nodes and normal thyroid
gland [3, 5]. In its original form, 4D-CT included a non-
contrast acquisition followed by three post-contrast acquisi-
tions that include an arterial phase (usually at 25 s) with
two additional scans obtained after variable delays [2, 3,
5]. In general, PAs have more rapid and greater arterial
phase enhancement and a more rapid rate of contrast
wash-out compared to the normal thyroid gland [5].
Lymph nodes are typically hypoenhancing compared to
PAs on arterial phase images, but demonstrate slow pro-
gressive enhancement on more delayed images, also a pat-
tern different from typical PAs [5]. The combination of
perfusion characteristics and high spatial resolution of CT
technique accounts for the success of 4D-CT [5], with
some studies reporting accuracy for lateralization of 94 %
[5]. As a result, there is increasing interest and use of 4D-
CT for PA identification and localization. However, one of
the concerns about 4D-CT is radiation exposure because of
multiple acquisitions. To this end, there are reports demon-
strating that not all of the phases described in the original
4D-CT protocol may be necessary for accurate PA
localization [11, 12]. Whereas one approach is to simply
eliminate one or more phases from conventional multi-
phasic CT, another approach is to use more advanced tech-
niques such as dual-energy CT for increasing the diagnostic
yield and therefore potentially reducing the number of ac-
quisition needed for a diagnostic exam.
Dual energy CT (DECT) is an advanced CT technique
that evaluates tissues at different X-ray energies, enabling
spectral evaluation and material tissue characterization
beyond what is possible with conventional CT [13–16].
Normally, the attenuation of different tissues and mate-
rials varies when scanned at high and low tube voltages,
depending on their specific elemental properties. With
DECT, projection data are typically obtained simultan-
eously or near-simultaneously at 80 and 140 kVp (kilovolt
peak) [14]. Using sophisticated computer algorithms, the
data at different acquisition energies can then be normal-
ized to specific combinations of two reference materials,
such as iodine, water or calcium. Furthermore, the
spectral data can be used to generate image sets at differ-
ent predicted energy levels (keV; kiloelectron volts),
referred to as virtual monochromatic images (VMI). As
such, DECT enables generation of virtual unenhanced
images as well as other advanced tissue characterization
not possible with conventional CT, all done by post-
processing and without the need for any additional scan
acquisitions. There are emerging applications of DECT in
all of the major subspecialties in radiology [16–22]. In the
head and neck, there is increasing evidence that DECT
can improve visualization of head and neck squamous cell
carcinoma and increase accuracy for evaluation of thyroid
cartilage invasion, among other applications [13, 22–28].
Currently, there are only isolated reports of DECT for
localization of PAs [29] but no systematic evaluation of this
technique. In this study, we prospectively evaluated the utility
ofmultiphasic DECTfor PA localization in a group of patients
having discordant or unidentified PAs on a workup consisting
at a minimum of ultrasound and sestamibi. A 3-phase DECT,
without an unenhanced phase, was performed with the ability
to create virtual unenhanced images as needed if needed for
diagnostic evaluation. This was followed by a post-hoc spec-
tral density evaluation of PAs and lymph nodes.
Methods
Patients
The study was approved by the institutional review
board at the Jewish General Hospital. In the period
from September 2013 to April 2014, after obtaining
consent, we recruited all patients with primary hyper-
parathyroidism and non-concordant imaging studies
(Table 1). At our institution, the standard studies
used for PA localization are ultrasound and sestamibi
SPECT/CT and all patients had undergone these stud-
ies. However, some patients had undergone additional
investigations, including MRIs (15/29) and seven pa-
tients who had undergone a total of nine negative
surgical explorations (Table 1). Non-concordance was
defined as either unidentified (i.e. standard imaging
fails to identify any PA) or discordant (i.e. standard
imaging does not agree on the location). Demographic
data was recorded and patients were divided into “un-
identified” or “discordant” groups. Patients with a his-
tory of iodine allergy were excluded from the study.
CT technique
All patients were scanned with the same 64-section dual-
energy scanner (GE Discovery CT750HD; GE Healthcare,
Milwaukee, WI). Scans were obtained at 25, 55, and 85 s
after injection of 100 mL of iopamidol at 3.5 mL/s. The 25
and 55 s acquisitions were acquired in dual-energy rapid
80–140-kVp switching mode using the gemstone spectral
imaging protocol [13]. These were acquired with a GSI pre-
set 1, with a large scan field of view (up to 50 cm), 40-mm
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beam collimation, 0.6-second rotation time, and
0.984:1 helical pitch, resulting in a maximal tube
current of approximately 640 mA. Images were re-
constructed into 1.25 mm sections with 25-cm dis-
play field of view and 512 × 512 matrix. 70 keV VMIs,
the VMI believed to simulate the standard 120 kVp single
energy acquisition by extrapolation from abdominal CT
studies, were reconstructed and transferred to PACS for
interpretation. Source spectral images were transferred to
a dedicated workstation (GE Advantage workstation 4.6;
GE Healthcare, Milwaukee, WI) where virtual unenhanced
image reconstruction or more advanced spectral analysis
could be performed.
Prospective PA identification
The scans were prospectively reviewed by one of two
attending head and neck radiologists with 5 (R.F.)
and 15 (M.L.) years post-fellowship experience in
head and neck radiology. Primary interpretation and
prospective localization of PAs was performed using
the multiphasic 70 keV VMIs. If needed, additional
virtual unenhanced images were generated to help
image interpretation at the discretion of the report-
ing radiologist. If virtual unenhanced images were
used to assist interpretation, this was recorded. If
patient was called back for additional imaging, such
as to obtain true unenhanced images, this was also
recorded. Potential candidate adenomas were
described based on their size, shape, presence of an
identifiable supplying artery (referred to as polar
artery), and exact anatomic location with respect to
the thyroid gland and associated cartilages. Depending on
ability to localize a potential adenoma, the study was
termed “DECT positive” or “DECT negative”.
Surgical confirmation
The imaging findings were compared with localization
during minimally invasive surgery and histopathologic
confirmation. Sensitivity was calculated for pre-operative
identification of correct side and quadrant. Successful
surgical excision was considered based on histopath-
ology and a decrease in the level of blood serum para-
thyroid hormone of greater than 50 % post-operatively.
Post-hoc advanced DECT characterization
Since little is known about the spectral characteristics
of PAs, a post-hoc analysis of spectral curves of a
subset of PAs [13] was performed and compared to
lymph nodes in order to evaluate for potential differ-
ences in their spectral characteristics. Analysis was
performed on the dedicated GE Advantage worksta-
tion (4.6; GE Healthcare, Milwaukee, WI). Quantita-
tive image analysis was performed using region of
interest (ROI) analysis. Scans were retrospectively
reconstructed into different VMI energy levels ranging
from 40 to 140 keV in 5 keV increments. PA and
lymph node evaluation was performed by measuring mean
CT attenuation (in Hounsfield units; HU) ± standard devi-
ation (SD) within regions of interest (ROIs) across the
entire range of VMI energy levels. All ROIs were placed
by an attending head and neck radiologist (R.F.). ROIs
were placed on the homogenous enhancing part of PAs or
lymph nodes, excluding any heterogenous or cystic foci
within the PA if present. Care was also taken not to over-
lap with adjacent tissues in order to avoid volume aver-
aging with other tissues. Because of frequently small size
of PAs and lymph nodes, small ROIs had to be used. How-
ever, to obtain a representative sample, 3 ROIs were
obtained in each structure and the mean attenuation of
the 3 ROIs calculated at each energy level for each struc-
ture. Each ROI was large enough to cover the enhancing
area without overlap with heterogenous or cystic internal
foci or adjacent tissue. For lymph nodes, normal lymph
nodes were selected, avoiding areas obscured by
artifact. When possible, nearby nodes (level VI or IV)
were selected. If those were too small for analysis, then
a level IB or IIA node was selected for analysis. The
average area for each individual ROI used was
5.62 mm2 (range 1.05–10.15 mm2).
Statistical analysis
Positive predictive value was calculated for PA identifica-
tion and final pathology in the unidentified and discord-
ant studies. For quantitative ROI analysis, results were
reported as mean ± SD. Spectral Hounsfield attenuation
curves were generated from 40 to 140 keV, in 5 keV in-
crements for comparison of PAs and LNs. For each
structure (PA or lymph node), the average density was
determined by calculating the average of the three ROIs
Table 1 Patient population and clinical presentation (p > 0.05
for all demographic data)
Discordant Unidentified
Subjects included 18 11
Average age 63.61 54.36
F:M ratio 12:6 7:4
Symptoms
Incidental hypercalcemia 14 8
Osteopenia/porosis 2 2





Surgical exploration 5 4
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used per structure in that patient. Data from different patients
were then pooled at each keV for comparison of PAs with
lymph nodes. Comparison of means was performed using an
unpaired two-tailed t-test. A p-value less than 0.05 was con-
sidered to be statistically significant. We used Graphpad
Prism version 6.005 for statistical analysis (GraphPad Soft-
ware, La Jolla California USA, www.graphpad.com, Graph-
Pad Software, Inc., La Jolla, CA).
Results
Patient population and clinical presentation
In total, 29 patients were evaluated in this study, 11 in
the unidentified and 18 in the discordant groups
(Table 1). The average age of participants was 60.1 years
old (range 39–76), consisting of 19 women and 10 men.
The most common presenting complaint was asymp-
tomatic incidental hypercalcemia with elevated parathy-
roid hormone, but presentations ranged from osteopenia
to renal failure (Table 1). Total counts for imaging/pro-
cedures performed prior to DECT included: 33 ultra-
sounds, 43 sestamibi scans, 15 MRIs, and nine previous
exploratory procedures (on seven patients).
Prospective parathyroid adenoma identification and
surgical outcome
Multiphasic dual-energy CTs localized potential PAs in
26 of 29 patients: 10/11 in the equivocal and 16/18 in
the discordant group. One patient in the latter group
had two candidate adenomas identified, corresponding
to a 94.4 % “DECT positive” rate overall. Of the 26
DECT positive studies, 23 patients have undergone min-
imally invasive parathyroidectomy at this time and 20
operations were successful (PPV 87.0 %). Both adenomas
in the patient with bilateral disease were histologically
positive corresponding to 21 adenomas total and an
87.5 % PPV overall. Of the seven patients with previous
negative surgical explorations, DECT found candidate
adenomas in six. Operations were successful (positive
localization and pathology) in four of the six patients. Of
the three studies in which the DECT identified candidate
could not be confirmed surgically, two were from the
discordant and one from the unidentified group.
Among the 20 patients with pathologically proven
PAs, DECT was concordant with the sestamibi SPECT/
CT in seven cases but US in only one case. Basic char-
acteristics of PAs are summarized in Table 2 and the
location of the PAs in the discordant and unidentified
groups is summarized in Table 3. Sizes ranged from 0.6
to 2.7 cm and means were similar in the two groups
(1.43 cm discordant vs. 1.24 cm unidentified). Perfusion
characteristics were a key component of PA identifica-
tion, particularly on the 25 s arterial phase images
(Fig. 1). However, not all PAs demonstrated typical ro-
bust arterial phase enhancement or rapid washout and
as such, other features were also important in identify-
ing and localizing a PA (Table 2, Figs. 2 and 3). These
included features that allowed confident separation of
the PA from the thyroid gland, such as presence of fat
plane between the PA and thyroid, perfusion pattern
distinct from thyroid gland, and other morphologic
characteristics enabling reliable distinction from lymph
nodes (Table 2).
Advanced DECT analysis
In the 29 patients evaluated here, the radiologists cre-
ated virtual unenhanced images in only two of the cases










Low attenuation component (%) 28.6
Fat plane separating from thyroid (%) 85.7










Table 3 Location of PAs in the discordant and equivocal
groups
Pathologically-proven (N = 21)
DECT characteristics Discordant Unidentified
Positive 14 7
Location (% of total (21); Perrier
classification [37])
A (4.8) A (0)
B (9.4) B (0)
C (18.9) C (4.8)
D (14.3) D (14.3)
E (0) E (4.8)
F (14.3) F (4.8)
G (4.8) G (4.8)
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and these were deemed not to be helpful. The limitation
of virtual unenhanced images for PA localization is that
in addition to the enhancing PA, the intrinsic iodine
content of the thyroid gland is also suppressed (Fig. 4).
As such, DECT virtual unenhanced images cannot be
used as a complete substitute for the unenhanced CT for
purposes of PA characterization. Early during recruit-
ment, two out of 29 patients were called back in order
to obtain actual unenhanced images. On retrospective
evaluation, it was felt that these did not add significantly
to the study and no patients were recalled for obtaining
unenhanced CT during the work-up of the latter 20
patients in this study.
As part of this pilot study using DECT, a post-hoc quan-
titative spectral Hounsfield unit attenuation curve analysis
was performed, comparing characteristics of PAs to lymph
nodes (Fig. 5). On the 25 s arterial acquisition, there was a
significant difference between the spectral attenuation
curves of PAs compared to lymph nodes, with density
separation in the low energy range (P < 0.01 - P < 0.0001;
Fig. 5). Although there was a trend for density separation
in the lower energy range on the 55 s acquisition, this was
not statistically significant (Fig. 5).
Discussion
Primary hyperparathyroidism (PHPT) is most commonly
caused by a solitary benign parathyroid adenoma and
the treatment is surgical excision [30]. In order to limit
the extent of dissection in searching for the pathologic
gland, preoperative localization studies are used [31].
These studies currently include sestamibi scanning,
ultrasonography, computed tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography
(PET) and angiography [2, 3, 32–34]. Pre-operative con-
cordant images have a dramatic impact on success and
associated morbidity of minimally invasive surgery [35].
There is increasing popularity of 4D-CT for
localization of PAs although there are concerns about
the radiation exposure associated with the classic 4
phase 4D-CT [3, 5–10]. While the effective dose of the
typical 4D-CT protocol is greater than that of scintig-
raphy, studies have shown the lifetime incidence of can-
cer compared to baseline cancer risk for this population
is negligible for either study [36]. Despite this and in
order to minimize radiation exposure from the proced-
ure to the extent possible, some groups are decreasing
the number of acquisitions [11, 12]. DECT scans can be
Fig. 1 Typical perfusion characteristics in an intrathyroidal parathyroid adenoma. 70 keV VMIs at (a, b) 25 s and (c, d) 55 s are shown of a
surgically and pathologically proven intrathyroidal parathyroid adenoma (large arrow). The feeding vessel supplying the adenoma is also
seen (small arrow) and is helpful for diagnosis, sometimes referred to as the polar artery. There is the typical rapid and robust enhancement on arterial
phase images (a, b). On the more delayed images, there is contrast washout from the adenoma but increased attenuation of the thyroid gland and
the adenoma cannot be clearly distinguished from the thyroid gland (c, d)
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used to create virtual unenhanced images or iodine
overlay maps that can estimate the iodine content of a
structure based on a single acquisition [14, 15]. In
addition, virtual monochromatic images can be created at
different energy levels, and these can be evaluated quantita-
tively, potentially increasing the analytic capabilities of CT
technique [13–15]. This could potentially improve accur-
acy and in turn enable a reduced number of acquisitions.
In this investigation, we used a 3 phase CT technique,
with DECT acquisitions, to localize unidentified or dis-
cordant PAs prospectively. Consistent with other studies
[3, 5–12], multiphasic CT was effective in localizing PAs
in a significant percentage of cases, including cases of
multi-gland disease and intrathyroidal PA. Although the
radiologists had the ability to generate and use virtual
unenhanced images, this was overall deemed not neces-
sary and after the use for two cases in the early part of
the study, without benefit, these were not created or
used for the other cases. The problem of using virtual
unenhanced images for PA identification is that both the
iodinated contrast in the enhancing PA and the intrinsic
iodine within the thyroid gland are suppressed (Fig. 4),
Fig. 2 Atypical perfusion characteristics in bilateral parathyroid adenomas. (a) 25 s 70 keV VMI, (b) 55 s 70 keV VMI, (c) 25 s 50 keV VMI, and (d)
25 s iodine overlay map are shown demonstrating surgically and pathologically proven bilateral parathyroid adenomas (arrows). In this case, a
typical robust arterial phase enhancement with rapid washout is not shown (adenoma attenuation on the 25 s images was less than 100 HU).
However, the presence of a fat plane separating the adenomas from the thyroid gland, location, and different appearance from normal lymph
nodes enabled a confident pre-operative diagnosis in this case. The 50 keV VMI (c) is shown as an example of how DECT low energy reconstructions
can accentuate the density of enhancing/iodine containing structures (compare c to a). DECT also enables creation of iodine overlay
maps (d), highlighting the iodine content of tissues and enabling a quantitative estimation of tissue iodine content
Fig. 3 Parathyroid adenoma with cystic internal change. Example of
surgically and pathologically proven parathyroid adenoma (arrow)
extending to the right tracheo-esophageal groove
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defeating the purpose of the reconstructions for distinc-
tion of PA from thyroid tissue. On the other hand, we
also demonstrate successful identification of PAs pro-
spectively without the need for an unenhanced scan.
During the early part of the study, two patients were
called back for an unenhanced study. However, in retro-
spect these were deemed not necessary and were not
performed in any of the patients later on. This is consist-
ent with more recent reports demonstrating successful
“4D-CT” with a reduced number of phases [11, 12].
Although our investigation did not reveal a role for the
DECT virtual unenhanced images for PA localization,
post-hoc spectral Hounsfield unit attenuation curve ana-
lysis demonstrated a difference in the characteristics of
PAs compared to lymph nodes on arterial phase images
(Fig. 5). Arterial phase images are one of the most import-
ant acquisitions in 4D-CT performed for PA localization
and these preliminary observations suggest that DECT
can further increase accuracy during this phase of the
exam, which may in turn enable further reduction of the
number of acquisitions without decreasing diagnostic ac-
curacy in the future. Other potential applications of DECT
could be improved PA visualization on low energy virtual
monochromatic images and the use of estimated iodine
content for PA identification (Fig. 2). These are topics of
great interest for future research.
Although the perfusion characteristics are central in
identifying PAs, other features such as location, presence
of feeding or polar artery, and other characteristics that
help distinguish PAs from normal lymph nodes such as
cystic internal change were also important for accurate
identification of PAs (Table 2). Furthermore, not all of
the PAs demonstrated a typical robust arterial phase
enhancement with rapid wash-out (Fig. 2). Therefore,
rather than focusing on absolute thresholds, it may be
more important to identify combinations of features that
help distinguish PAs from potentially mimicking normal
Fig. 4 Virtual unenhanced DECT images. a 70 keV VMI and (b) virtual unenhanced image of the intrathyroidal parathyroid adenoma in Fig. 1 are
shown. The parathyroid adenoma seen on the 70 keV VMI (arrow) cannot be seen on the virtual unenhanced image (b) because of suppression
of iodinated contrast on that image. The iodinated contrast in the vessels as well as iodine within the thyroid gland are also suppressed
Fig. 5 Spectral Hounsfield unit (HU) curve analysis of parathyroid
adenomas compared to lymph nodes. Spectral HU analysis of 13
normal appearing lymph nodes (LN) and 14 surgical and pathologically
proven adenomas (PA) from 13 patients are shown from the
(a) 25 s and (b) 55 s DECT acquisitions. PA have different spectral HU
characteristics compared to LN on the 25 s but not the 55 s acquisition
with density separation on the left (lower energy) side of the curve.
**P < 0.01, ***P < 0.001, ****P < 0.0001
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structures. Of course, it is possible that we observed a
higher frequency of atypical appearing PAs because the
study was used to evaluate unidentified or discordant
PAs, resulting in a selection bias.
In this study, we were able to localize previously un-
identified parathyroid adenomas in 26 of 29 patients.
Twenty three of these patients have undergone surgical
exploration at this time, and DECT correctly identified
21 PAs in 20 of those patients. We also demonstrate a
high success-rate of minimally invasive parathyroidec-
tomy on primary cases and even some secondary cases.
Among the three false positives, two were in patients
with prior surgery. Therefore, one must at least consider
the possibility that these PAs may have not been found
because of extensive scarring from the patient’s prior
surgery. One of the strengths of this study is that all PA
identification was done prospectively. The limitation is
that the numbers are relatively small. As many of these
were outside referrals, another limitation could be that
not all of the standard imaging was done at the institu-
tion were DECT was performed, potentially introducing
a bias. However, among the 20 patients who successfully
underwent surgery, 13 had sestamibi and 12 US at the
same institution and therefore the proposed bias could
not account for the success of DECT in these cases. In
addition, a small number of patients could not be
analyzed because they have not undergone surgery yet
(either because of loss to follow-up or surgical wait-
list time). Nonetheless, our results demonstrate the
feasibility of a multiphasic study without an unenhanced
phase and promising results for DECT spectral analysis
for improving the diagnostic evaluation of PAs. The
impact of more advanced DECT analysis will have to
be tested in larger and ideally prospective use of these
characteristics in future studies.
Conclusion
In this prospective study, we demonstrate that a 3 phase
CT technique, with DECT acquisitions and without an
unenhanced phase, has high accuracy in identifying pre-
viously unidentified or discordant PAs. Furthermore, our
post-hoc analysis demonstrates significant differences in
the spectral characteristics of PAs compared to lymph
nodes on arterial phase images. This suggests that
advanced DECT analysis has the potential to further
increase accuracy for PA identification, which could
potentially enable a reduction in the number of CT
acquisitions and associated radiation exposure. This is
an interesting topic for future research.
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